Atossa Genetics

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$0
$0
$0
$18
Gross Profit
-4
-5
EBITDA
-7,147
-6,381
-7,101
-6,975
EBIT
-7,151
-6,385
-7,105
-6,980
Net Income
-6,347
-7,230
-6,049
-5,878
Net Change In Cash
0
0
0
18
Free Cash Flow
-7,051
-4,760
-4,534
-4,704
Cash
71,084
74,766
79,526
84,070
Basic Shares
125,772
125,772
125,732
125,319

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-23
-8
-23
EBITDA
-31,354
-27,683
-20,498
EBIT
-31,377
-27,691
-20,521
Net Income
-25,504
-30,094
-26,229
-20,606
Net Change In Cash
0
0
0
0
Cost of Revenue
-25,487
96,823
Free Cash Flow
-21,049
-20
-20,787
-16,481
Cash
71,084
88,460
110,890
136,377
Basic Shares
125,801
126,081
126,624
116,950

Earnings Calls

Quarter EPS
2024-12-31
-$0.05
2024-09-30
-$0.05
2024-06-30
-$0.05
2024-03-31
-$0.05